Dynavax Technologies (DVAX) Common Equity: 2009-2025
Historic Common Equity for Dynavax Technologies (DVAX) over the last 15 years, with Sep 2025 value amounting to $534.1 million.
- Dynavax Technologies' Common Equity fell 21.61% to $534.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $534.1 million, marking a year-over-year decrease of 21.61%. This contributed to the annual value of $596.8 million for FY2024, which is 4.06% down from last year.
- Latest data reveals that Dynavax Technologies reported Common Equity of $534.1 million as of Q3 2025, which was up 8.09% from $494.2 million recorded in Q2 2025.
- In the past 5 years, Dynavax Technologies' Common Equity registered a high of $681.4 million during Q3 2024, and its lowest value of $67.6 million during Q3 2021.
- Over the past 3 years, Dynavax Technologies' median Common Equity value was $596.8 million (recorded in 2024), while the average stood at $587.9 million.
- Its Common Equity has fluctuated over the past 5 years, first soared by 743.72% in 2021, then dropped by 23.13% in 2025.
- Over the past 5 years, Dynavax Technologies' Common Equity (Quarterly) stood at $222.4 million in 2021, then soared by 161.28% to $581.0 million in 2022, then rose by 7.07% to $622.1 million in 2023, then dropped by 4.06% to $596.8 million in 2024, then dropped by 21.61% to $534.1 million in 2025.
- Its Common Equity was $534.1 million in Q3 2025, compared to $494.2 million in Q2 2025 and $530.9 million in Q1 2025.